Search Within

David Hyman

Formats
  1. Meeting Abstract (174)
  2. Journal Article (170)
  3. Review (4)
  4. Research Letter (3)
  5. Editorial (2)
  6. Book Section (1)
Groups
  1. Department of Medicine (354)
  2. Early Drug Development Service (354)
  3. Solid Tumor Oncology Division (354)
  4. GSK Faculty (210)
  5. Department of Pathology and Laboratory Medicine (167)
  6. Human Oncology and Pathogenesis Program (167)

More Groups

People
  1. David Solit (107)
  2. Michael Berger (105)
  3. Marc Ladanyi (81)
  4. Alexander Drilon (78)
  5. Ahmet Zehir (75)
  6. Jose Baselga (68)

More People

Years
  1. 2024 (1)
  2. 2022 (4)
  3. 2021 (9)
  4. 2020 (44)
  5. 2019 (74)
  6. 2018 (57)

More Years

Publications
  1. Journal of Clinical Oncology (81)
  2. Cancer Research (32)
  3. Clinical Cancer Research (26)
  4. Annals of Oncology (22)
  5. Blood (19)
  6. Cancer Discovery (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. American Association for Cancer Research (82)
  3. Oxford University Press (26)
  4. Nature Publishing Group (23)
  5. Elsevier Inc. (22)
  6. American Society of Hematology (20)

More Publishers

Results (354)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • BRCA1 immunohistochemistry in high-grade serous ovarian cancers (HGS-OC) characterized for BRCA1 germ-line mutations
    Meeting Abstract

    Hyman, D. M.; Garg, K.; Grisham, R. N.; Bhatia, J.; Arnold, A. G.; Aghajanian, C.; Kauff, N. D.; Levine, D. A.; Soslow, R. A.; Spriggs, D. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A comprehensive analysis of BRAF and KRAS mutation status in low-grade serous (LGS) and serous borderline (SB) ovarian cancer (OC)
    Meeting Abstract

    Grisham, R. N.; Garg, K.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Hyman, D. M.; Levine, D. A.; Solit, D. B.; Aghajanian, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase i clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
    Journal Article

    Konner, J.; Grisham, R. N.; Park, J.; O'Connor, O. A.; Cropp, G.; Johnson, R.; Hannah, A. L.; Hensley, M. L.; Sabbatini, P.; Mironov, S.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase i trials
    Journal Article

    Iasonos, A.; Gounder, M.; Spriggs, D. R.; Gerecitano, J. F.; Hyman, D. M.; Zohar, S.; O'Quigley, J.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer
    Journal Article

    Hyman, D. M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; Arnold, A. G.; Phillips, M. F.; Bhatia, J.; Levine, D. A.; Aghajanian, C.; Offit, K.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma
    Journal Article

    Hyman, D. M.; Long, K. C.; Tanner, E. J.; Grisham, R. N.; Arnold, A. G.; Bhatia, J.; Phillips, M. F.; Spriggs, D. R.; Soslow, R. A.; Kauff, N. D.; more...
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Gemcitabine for advanced endometrial cancer: A retrospective study of the Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Grisham, R. N.; Adaniel, C.; Hyman, D. M.; Ma, W.; Iasonos, A.; Aghajanian, C.; Konner, J.
    International Journal of Gynecological Cancer (2012)

    Fulltext@MSK | Save
  • Unwrapping the implications of BRCA1 and BRCA2 mutations in ovarian cancer
    Journal Article

    Hyman, D. M.; Spriggs, D. R.
    JAMA - Journal of the American Medical Association (2012)

    Fulltext@MSK | Save
  • Topoisomerase I inhibition in BRCA+ and BRCA- ovarian cancer (OC): A single-institution experience
    Meeting Abstract

    Hyman, D. M.; Zhou, Q.; Arnold, A. G.; Grisham, R. N.; Bhatia, J.; Aghajanian, C.; Iasonos, A.; Spriggs, D. R.; Kauff, N. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save